Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.05
+0.05 (0.13%)
Jun 3, 2026, 1:30 PM CST

TPEX:4160 Revenue

Genetics Generation Advancement had revenue of 149.38M TWD in the quarter ending March 31, 2026, with 4.19% growth. This brings the company's revenue in the last twelve months to 609.13M, down -4.58% year-over-year. In the year 2025, Genetics Generation Advancement had annual revenue of 603.11M, down -8.88%.

Revenue (ttm)
609.13M
Revenue Growth
-4.58%
P/S Ratio
1.77
Revenue / Employee
5.86M
Employees
104
Market Cap
1.08B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025603.11M-58.74M-8.88%
Dec 31, 2024661.86M69.36M11.71%
Dec 31, 2023592.50M44.69M8.16%
Dec 31, 2022547.81M28.30M5.45%
Dec 31, 2021519.51M76.38M17.24%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BIONET1.26B
DIVA Laboratories884.63M
Kim Forest Enterprise549.14M
Sofiva Genomics382.82M
Welgene Biotech381.82M
Pharmigene199.89M
Puriblood Medical82.34M
Revenue Rankings